Market Cap ₹203 Cr.
Stock P/E -21.0
P/B 1.7
Current Price ₹156.3
Book Value ₹ 91
Face Value 10
52W High ₹201
Dividend Yield 0%
52W Low ₹ 114.1
Shiva Texyarn Ltd manufactures and markets cotton yarn, and technical and different value-added fabric merchandise in India and the world over. The organization gives combed, carded, and compact yarns; slub and fancy yarns; quick dry merchandise; quick healthy products, consisting of mattresses protectors; and baby merchandise below the Q-Club logo. It also offers door, window, and bathe curtains, in addition to cushion covers; knitwear, light weight shells, seam sealed, multi layered, fleece and pile fabric, and breathable movie laminated garments; and extreme cold weather garb, super high altitude mountaineering clothing, intense cold climate combat glove structures, and inner and external frame rucksacks. In addition, the corporation gives bedding range, together with sheets, cover covets, and fleece blankets; kitchen articles comprising aprons, pot holders, and table cloths; tub, wipe, and swimming towels; acrylic coated, PU coating products, and artwork canvas and virtual canvas merchandise; and luggage, together with sports and school baggage, and women and professional luggage for camping and photography beneath the WULF call. The agency was incorporated in 1980 and is primarily based in Coimbatore, India. As of February 21, 2022, Shiva Texyarn Ltd operates as a subsidiary of Vedanayagam Hospital (p) Ltd.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 83 | 97 | 109 | 86 | 114 | 150 | 127 | 128 | 97 | 90 |
| Other Income | 0 | 3 | 4 | 0 | 0 | 0 | 1 | 0 | 16 | 0 |
| Total Income | 84 | 99 | 113 | 86 | 115 | 150 | 128 | 128 | 113 | 91 |
| Total Expenditure | 72 | 85 | 98 | 72 | 96 | 134 | 120 | 120 | 98 | 90 |
| Operating Profit | 11 | 15 | 15 | 14 | 18 | 17 | 8 | 8 | 15 | 0 |
| Interest | 5 | 4 | 4 | 4 | 3 | 4 | 2 | 4 | 2 | 3 |
| Depreciation | 3 | 4 | 5 | 3 | 3 | 3 | 3 | 3 | 4 | 4 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 3 | 7 | 6 | 7 | 12 | 9 | 2 | 1 | 9 | -6 |
| Provision for Tax | 1 | 1 | 2 | 2 | 4 | 3 | 1 | 0 | 3 | -0 |
| Profit After Tax | 2 | 6 | 4 | 5 | 8 | 6 | 1 | 1 | 6 | -6 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | -0 | 0 |
| Profit After Adjustments | 2 | 6 | 4 | 5 | 8 | 6 | 1 | 1 | 6 | -6 |
| Adjusted Earnings Per Share | 1.7 | 4.3 | 2.9 | 3.8 | 6.3 | 4.6 | 0.7 | 0.5 | 4.9 | -4.6 |
| #(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 419 | 504 | 465 | 450 | 383 | 359 | 354 | 368 | 341 | 477 | 411 | 442 |
| Other Income | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 5 | 7 | 1 | 16 | 17 |
| Total Income | 420 | 506 | 466 | 451 | 385 | 361 | 355 | 373 | 348 | 478 | 427 | 460 |
| Total Expenditure | 348 | 432 | 411 | 396 | 335 | 314 | 312 | 334 | 298 | 422 | 403 | 428 |
| Operating Profit | 73 | 74 | 55 | 55 | 50 | 47 | 43 | 38 | 50 | 56 | 24 | 31 |
| Interest | 27 | 23 | 25 | 23 | 21 | 19 | 22 | 22 | 18 | 14 | 14 | 11 |
| Depreciation | 19 | 20 | 17 | 17 | 13 | 13 | 13 | 15 | 16 | 13 | 14 | 14 |
| Exceptional Income / Expenses | 5 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 32 | 30 | 13 | 15 | 16 | 15 | 8 | 1 | 17 | 30 | -4 | 6 |
| Provision for Tax | 9 | 9 | 4 | 4 | 6 | 3 | 1 | -0 | 4 | 10 | 3 | 4 |
| Profit After Tax | 22 | 21 | 9 | 11 | 10 | 11 | 7 | 2 | 12 | 20 | -7 | 2 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 22 | 21 | 9 | 11 | 10 | 11 | 7 | 2 | 12 | 20 | -7 | 2 |
| Adjusted Earnings Per Share | 10.3 | 9.7 | 4.1 | 5 | 4.8 | 8.7 | 5.2 | 1.2 | 9.5 | 15.4 | -5.1 | 1.5 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -14% | 4% | 3% | -0% |
| Operating Profit CAGR | -57% | -14% | -13% | -11% |
| PAT CAGR | -135% | NAN% | NAN% | NAN% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 32% | -6% | -2% | 19% |
| ROE Average | -5% | 7% | 6% | 8% |
| ROCE Average | 4% | 11% | 10% | 11% |
| #(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 127 | 145 | 151 | 159 | 99 | 108 | 112 | 111 | 124 | 142 | 134 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 143 | 130 | 95 | 87 | 58 | 72 | 78 | 70 | 56 | 47 | 43 |
| Other Non-Current Liabilities | 32 | 41 | 43 | 44 | 40 | 40 | 21 | 21 | 23 | 25 | 37 |
| Total Current Liabilities | 139 | 219 | 175 | 191 | 155 | 141 | 156 | 153 | 121 | 147 | 95 |
| Total Liabilities | 440 | 534 | 464 | 481 | 352 | 361 | 366 | 355 | 323 | 361 | 308 |
| Fixed Assets | 299 | 297 | 293 | 289 | 213 | 209 | 201 | 201 | 174 | 172 | 197 |
| Other Non-Current Assets | 31 | 30 | 38 | 37 | 25 | 26 | 10 | 6 | 9 | 22 | 12 |
| Total Current Assets | 110 | 206 | 133 | 154 | 114 | 125 | 155 | 148 | 140 | 167 | 99 |
| Total Assets | 440 | 534 | 464 | 481 | 352 | 361 | 366 | 355 | 323 | 361 | 308 |
| #(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 10 | 20 | 19 | 7 | 4 | 3 | 4 | 4 | 1 | 1 | 3 |
| Cash Flow from Operating Activities | 109 | -27 | 93 | 27 | 45 | 17 | 14 | 41 | 69 | 20 | 67 |
| Cash Flow from Investing Activities | -11 | -12 | -16 | -12 | -6 | -9 | -9 | -5 | 16 | -25 | -6 |
| Cash Flow from Financing Activities | -89 | 39 | -89 | -14 | -39 | -7 | -5 | -39 | -84 | 5 | -64 |
| Net Cash Inflow / Outflow | 9 | -0 | -13 | 1 | -1 | 0 | 1 | -3 | 1 | -0 | -2 |
| Closing Cash & Cash Equivalent | 20 | 19 | 7 | 8 | 3 | 4 | 4 | 1 | 2 | 1 | 1 |
| # | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 10.32 | 9.66 | 4.12 | 5.02 | 4.76 | 8.74 | 5.17 | 1.19 | 9.47 | 15.44 | -5.12 |
| CEPS(Rs) | 19.19 | 18.95 | 11.93 | 12.95 | 10.7 | 19.1 | 15.48 | 12.53 | 21.57 | 25.2 | 5.76 |
| DPS(Rs) | 1.2 | 1.2 | 1 | 1.1 | 1.6 | 1.6 | 1.1 | 0 | 1.2 | 1.4 | 0 |
| Book NAV/Share(Rs) | 58.7 | 66.95 | 69.86 | 73.55 | 75.41 | 83.4 | 86.4 | 85.74 | 95.37 | 109.91 | 103.46 |
| Core EBITDA Margin(%) | 17.03 | 14.35 | 11.68 | 12.06 | 12.38 | 12.48 | 11.8 | 9.14 | 12.62 | 11.48 | 2.03 |
| EBIT Margin(%) | 13.89 | 10.59 | 8.2 | 8.45 | 9.62 | 9.45 | 8.39 | 6.39 | 10.06 | 9.13 | 2.49 |
| Pre Tax Margin(%) | 7.51 | 5.94 | 2.73 | 3.23 | 4.24 | 4.08 | 2.26 | 0.33 | 4.87 | 6.25 | -0.86 |
| PAT Margin (%) | 5.31 | 4.14 | 1.91 | 2.41 | 2.69 | 3.16 | 1.9 | 0.42 | 3.6 | 4.17 | -1.61 |
| Cash Profit Margin (%) | 9.87 | 8.12 | 5.53 | 6.21 | 6.03 | 6.9 | 5.68 | 4.41 | 8.21 | 6.81 | 1.81 |
| ROA(%) | 4.97 | 4.28 | 1.78 | 2.3 | 2.47 | 3.18 | 1.84 | 0.43 | 3.62 | 5.85 | -1.98 |
| ROE(%) | 19.02 | 15.37 | 6.02 | 7 | 6.39 | 8.36 | 6.09 | 1.39 | 10.46 | 15.04 | -4.8 |
| ROCE(%) | 15.58 | 13.59 | 9.39 | 9.7 | 11.01 | 12.25 | 9.88 | 7.73 | 12.66 | 16.61 | 4.01 |
| Receivable days | 26.78 | 27.91 | 30.44 | 30.03 | 36 | 39.24 | 46.86 | 48.56 | 44.02 | 22.94 | 21.56 |
| Inventory Days | 49.19 | 62.65 | 81.78 | 69.18 | 74.25 | 66.52 | 75.98 | 79.56 | 81.59 | 65.09 | 69.26 |
| Payable days | 46.71 | 50.37 | 47.8 | 35.78 | 47.28 | 56.42 | 48.25 | 45.36 | 61.01 | 30.22 | 23.81 |
| PER(x) | 2.37 | 2.58 | 9.52 | 20.64 | 76.67 | 53.78 | 33.25 | 67.29 | 14.83 | 13.29 | 0 |
| Price/Book(x) | 0.42 | 0.37 | 0.56 | 1.41 | 4.84 | 5.63 | 1.99 | 0.94 | 1.47 | 1.87 | 1.16 |
| Dividend Yield(%) | 4.9 | 4.81 | 2.55 | 1.06 | 0.44 | 0.34 | 0.64 | 0 | 0.85 | 0.68 | 0 |
| EV/Net Sales(x) | 0.62 | 0.64 | 0.66 | 1.02 | 2.48 | 2.17 | 1.16 | 0.77 | 0.86 | 0.83 | 0.59 |
| EV/Core EBITDA(x) | 3.58 | 4.39 | 5.57 | 8.35 | 19.11 | 16.48 | 9.56 | 7.4 | 5.85 | 7.03 | 9.96 |
| Net Sales Growth(%) | 26.27 | 20.35 | -7.77 | -3.3 | -14.94 | -6.24 | -1.47 | 4.13 | -7.42 | 39.99 | -13.88 |
| EBIT Growth(%) | 9152.93 | -8.38 | -28.53 | -0.41 | -3.17 | -7.89 | -12.57 | -20.65 | 45.64 | 27.83 | -76.56 |
| PAT Growth(%) | 214.77 | -6.41 | -57.37 | 21.95 | -5.18 | 10.1 | -40.8 | -76.92 | 693.83 | 62.96 | -133.18 |
| EPS Growth(%) | 214.77 | -6.41 | -57.37 | 21.96 | -5.18 | 83.49 | -40.8 | -76.92 | 693.84 | 62.96 | -133.18 |
| Debt/Equity(x) | 1.79 | 1.99 | 1.52 | 1.54 | 1.67 | 1.67 | 1.79 | 1.67 | 0.97 | 0.99 | 0.7 |
| Current Ratio(x) | 0.8 | 0.94 | 0.76 | 0.81 | 0.74 | 0.89 | 1 | 0.97 | 1.16 | 1.14 | 1.05 |
| Quick Ratio(x) | 0.48 | 0.35 | 0.31 | 0.33 | 0.32 | 0.42 | 0.48 | 0.44 | 0.56 | 0.46 | 0.43 |
| Interest Cover(x) | 2.18 | 2.28 | 1.5 | 1.62 | 1.79 | 1.76 | 1.37 | 1.06 | 1.94 | 3.17 | 0.74 |
| Total Debt/Mcap(x) | 4.28 | 5.34 | 2.71 | 1.09 | 0.21 | 0.3 | 0.9 | 1.79 | 0.66 | 0.53 | 0.61 |
| # | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74.04 | 74.04 | 74.04 | 74.04 | 74.04 | 74.04 | 74.04 | 74.04 | 74.04 | 74.04 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0 | 0 |
| DII | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 25.96 | 25.96 | 25.96 | 25.96 | 25.95 | 25.96 | 25.96 | 25.93 | 25.95 | 25.95 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.96 | 0.96 | 0.96 | 0.96 | 0.96 | 0.96 | 0.96 | 0.96 | 0.96 | 0.96 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
